BILLS-109hr5533eh.pdf
House Resolutions
0 pages
Page
of 0
Loading OCR text...
No OCR text available for this page.
Failed to load OCR text.
DATE (16)
2006
5533
1949
daily
each day
319F–1(a)(2
annual
September 26
15
years
one year
2008
each of the fiscal years 2007
the fiscal years 2007 and 2008
5533 EH
every 5 years
2004
EVENT (2)
SESSION
H. R. 5533
the ‘‘Biodefense
GPE (4)
United States
the United States
the United
States
the United States of America
NORP (2)
American
NATIONALS
ORG (50)
uct
SEC
the Public Health Service Act
U.S.C.
Board
the Department of Health
Federal
Drug Development Act
the Federal Government
Food, Drug
CONGRESS
DUTIES.—The Board
Defense
the Biomedical Advanced Research
NATIONAL BIODEFENSE SCIENCE BOARD
MENT AUTHORITY
APPOINTMENT.—A
Good Manufacturing Practice
2)(D
TIPLE
House of Representa-
Science Board
United
6
States
the Federal Property
EES.—Any Federal Government
the National Biodefense Science
the Department of Health and Human Serv-
the Federal Register
Biomedical Advanced Research and Development Authority
MEMBERS.—A
the Federal Food, Drug
Department of Health and Human Services
Federal Food, Drug
the Department of Health and Human
6
Services
Senate
National
Biodefense Science Board
MENTS
Project BioShield
Human Services
Administrative Services Act
MILESTONE
the Federal Advisory Committee
NATIONAL BIODEFENSE
7
SCIENCE BOARD
Federal Acquisition
Nation
the House of Representatives
the Federal Food
Biomedical Advanced Research and Development
PERSON (4)
PROJECT BIOSHIELD
DEFINITIONS.—Any
8)
Biodefense
Topic Classifications
congressional legislation
98.0%
public health
54.9%
government oversight
33.0%
Extracted Keywords
advanced research
biomedical
countermeasure
advanced
research development
research
research develop
facilitating
illness
sec table
department health
velopment
strengthen
development
prepare
Forensic Analysis
PDF Metadata
- Creator
- ACOMP.exe WinVer 1a68 0ct 09 2002
- ModDate
- D:20230111112048Z
- Producer
- Acrobat Distiller 6.0 (Windows); modified using iText® Core 7.2.3 (production version) ©2000-2022 iText Group NV, Government Publishing Office
- CreationDate
- D:20060926183319-04'00'
Sentiment
Polarity
Neutral
0.068
Subjectivity
49%
Objective
No crisis correlations found for this document.
The ML pipeline may still be processing.